Home Stock

Stock Research: Bastide Le Confort Medical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Bastide Le Confort Medical

PAR:BLC FR0000035370
20
  • Value
    31
  • Growth
    17
  • Safety
    Safety
    32
  • Combined
    24
  • Sentiment
    25
  • 360° View
    360° View
    20
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bastide le Confort Medical SA is a France-based company specializing in home health services for the elderly, ill, and handicapped. The company operates in home care equipment, respiratory assistance equipment, and perfusion and nutrition equipment, providing products such as hospital beds, respirators, oxygen concentrators, and insulin pumps. The company primarily operates in France. In the last fiscal year, the company had a market cap of $272 million, profits of $380 million, revenue of $568 million, and 3651 employees.

more

ANALYSIS: With an Obermatt 360° View of 20 (better than 20% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bastide Le Confort Medical are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Bastide Le Confort Medical. The consolidated Value Rank has a low rank of 31 which means that the share price of Bastide Le Confort Medical is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 69% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 17, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 17% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 32, which means that the company has a riskier financing structure than 68% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 25, which means that professional investors are more pessimistic about the stock than for 75% of alternative investment opportunities. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Refinancing
Country France
Industry Health Care Distributors
Size Small
Website bastideleconfortmedical.com
Index
CAC All
Bastide Le Confort Medical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
31 46 75 57
Growth
17 76 49 7
Safety
Safety
32 14 10 22
Sentiment
25 50 15 61
360° View
360° View
20 38 18 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
58 93 93 65
Opinions Change
3 2 11 50
Pro Holdings
n/a 14 18 28
Market Pulse
69 75 8 64
Sentiment
25 50 15 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
31 46 75 57
Growth
17 76 49 7
Safety Safety
32 14 10 22
Combined
24 23 28 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
75 82 89 71
Price vs. Earnings (P/E)
51 83 89 62
Price vs. Book (P/B)
37 50 63 47
Dividend Yield
1 1 60 46
Value
31 46 75 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
45 50 40 4
Profit Growth
23 100 85 48
Capital Growth
16 46 48 40
Stock Returns
35 72 19 23
Growth
17 76 49 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
1 8 6 5
Refinancing
84 19 13 43
Liquidity
37 26 30 37
Safety Safety
32 14 10 22

Similar Stocks

Discover high‑ranked alternatives to Bastide Le Confort Medical and broaden your portfolio horizons.

Rubis

PAR:RUI
Country: France
Industry: Gas Utilities
Size: Large
Full Stock Analysis

ENGIE

PAR:ENGI
Country: France
Industry: Multi-Utilities
Size: Large
Full Stock Analysis

L.D.C.

PAR:LOUP
Country: France
Industry: Packaged Foods & Meats
Size: Large
Full Stock Analysis

Groupe Crit

PAR:CEN
Country: France
Industry: HR- & Employment Services
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews